OM:DEDI

Stock Analysis Report

Executive Summary

Dedicare AB operates as a staffing company in the healthcare industry primarily in Sweden, Norway, Finland, and Denmark.

Snowflake

Fundamentals

Flawless balance sheet and good value.


Similar Companies

Share Price & News

How has Dedicare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.4%

DEDI

1.6%

SE Healthcare

2.7%

SE Market


1 Year Return

-24.3%

DEDI

-9.4%

SE Healthcare

10.0%

SE Market

Return vs Industry: DEDI underperformed the Swedish Healthcare industry which returned -9.4% over the past year.

Return vs Market: DEDI underperformed the Swedish Market which returned 10% over the past year.


Shareholder returns

DEDIIndustryMarket
7 Day-1.4%1.6%2.7%
30 Day0.1%2.4%1.9%
90 Day-1.6%7.0%3.2%
1 Year-18.8%-24.3%-8.1%-9.4%14.7%10.0%
3 Year-25.5%-38.5%-17.5%-21.5%31.1%11.4%
5 Year167.5%92.6%160.3%122.9%61.5%27.2%

Price Volatility Vs. Market

How volatile is Dedicare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Dedicare undervalued compared to its fair value and its price relative to the market?

47.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: DEDI (SEK44.3) is trading below our estimate of fair value (SEK83.89)

Significantly Undervalued: DEDI is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: DEDI is good value based on its PE Ratio (12.9x) compared to the Healthcare industry average (26.8x).

PE vs Market: DEDI is good value based on its PE Ratio (12.9x) compared to the Swedish market (16.7x).


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate DEDI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: DEDI is overvalued based on its PB Ratio (4.9x) compared to the SE Healthcare industry average (1.4x).


Next Steps

Future Growth

How is Dedicare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

-22.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: DEDI's earnings are forecast to decline over the next 3 years (-22.5% per year).

Earnings vs Market: DEDI's earnings are forecast to decline over the next 3 years (-22.5% per year).

High Growth Earnings: DEDI's earnings are forecast to decline over the next 3 years.

Revenue vs Market: Insufficient data to determine if DEDI's revenue is forecast to grow faster than the Swedish market.

High Growth Revenue: Insufficient data to determine if DEDI's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if DEDI's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Dedicare performed over the past 5 years?

13.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: DEDI's earnings have grown by 13.6% per year over the past 5 years.

Accelerating Growth: DEDI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DEDI had negative earnings growth (-27.7%) over the past year, making it difficult to compare to the Healthcare industry average (-15.7%).


Return on Equity

High ROE: DEDI's Return on Equity (38.1%) is considered high.


Return on Assets

ROA vs Industry: DEDI has a higher Return on Assets than the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: DEDI's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Dedicare's financial position?


Financial Position Analysis

Short Term Liabilities: DEDI's short term assets (SEK185.1M) exceeds its short term liabilities (SEK112.3M)

Long Term Liabilities: DEDI's short term assets (185.1M) exceeds its long term liabilities (25.8M)


Debt to Equity History and Analysis

Debt Level: DEDI is debt free.

Reducing Debt: DEDI had no debt 5 years ago.

Debt Coverage: DEDI has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: DEDI has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: DEDI has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if DEDI's debt is covered by short term assets.


Next Steps

Dividend

What is Dedicare's current dividend yield, its reliability and sustainability?

9.03%

Current Dividend Yield


Dividend Yield vs Market

company9.0%marketbottom25%1.8%markettop25%4.7%industryaverage1.7%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: DEDI's dividend (9.03%) is higher than the bottom 25% of dividend payers in the Swedish market (1.8%).

High Dividend: DEDI's dividend (9.03%) is in the top 25% of dividend payers in the Swedish market (4.67%)

Stable Dividend: DEDI has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: DEDI's dividend payments have increased, but the company has only paid a dividend for 8 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (116.3%), DEDI's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of Dedicare's salary, the management and board of directors tenure and is there insider trading?

7.5yrs

Average board tenure


CEO

Dedicare has no CEO, or we have no data on them.


Board Age and Tenure

7.5yrs

Average Tenure

63yo

Average Age

Experienced Board: DEDI's board of directors are considered experienced (7.5 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Buykr2,399,97917 May 19
Bjorn Oras
EntityIndividual
Role
Chairman of the Board
Chairman
Shares1,540,722
Max Pricekr1.56
Sellkr2,399,97917 May 19
Bjorn Oras
EntityIndividual
Role
Chairman of the Board
Chairman
Shares1,540,722
Max Pricekr1.56

Ownership Breakdown


Management Team

  • Lia Sandstrom (43yo)

    Chief Financial Officer

    • Tenure: 6.1yrs
  • Jenny Pizzignacco (40yo)

    Business Development Manager

    • Tenure: 0yrs

Board Members

  • Bjorn Oras (70yo)

    Chairman

    • Tenure: 12.8yrs
    • Compensation: kr379.00k
  • Dag Sundstrom (64yo)

    Director

    • Tenure: 6.5yrs
    • Compensation: kr160.00k
  • Anna Nordmark Nilsson (63yo)

    Director

    • Tenure: 7.5yrs
    • Compensation: kr160.00k
  • Anna Lefevre Skjoldebrand (50yo)

    Director

    • Tenure: 8.7yrs
    • Compensation: kr160.00k
  • Kristian Faeste (57yo)

    Board Member

    • Tenure: 3.5yrs

Company Information

Dedicare AB's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Dedicare AB
  • Ticker: DEDI
  • Exchange: OM
  • Founded: 1996
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: kr401.154m
  • Shares outstanding: 9.06m
  • Website: https://www.dedicare.se

Location

  • Dedicare AB
  • Ringvägen 100
  • uppgång E, 10 tr
  • Stockholm
  • Stockholm County
  • 118 60
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DEDIOM (OMX Nordic Exchange Stockholm)YesClass B SharesSESEKMay 2011
DEDISBATS-CHIXE (BATS 'Chi-X Europe')YesClass B SharesGBSEKMay 2011

Biography

Dedicare AB operates as a staffing company in the healthcare industry primarily in Sweden, Norway, Finland, and Denmark. The company hires and recruits doctors, nurses, social workers, and managers, as wel ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/17 21:08
End of Day Share Price2019/10/17 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.